IMP

Europe PMC · fetched just now · sorted by publication date

1. 1
   Nanoparticle-based therapeutic platforms for inflammatory disorders of the urinary system: Engineering local delivery, biointerface regulation, and smart responsive therapy.

   Wang W, Ma J, Hou C, Chen J, Ni K. · 2026-09-16

   open access unreviewed
2. 2
   Distinct metabolomic signatures of SGLT2 inhibitor vs. sulfonylurea in a paired human liver biopsy study.

   Takeshita Y, Oo HK, Nakano Y, Ueno A, Oishi M, Tsujiguchi H, Soga T, Yamashita T, Honda M, Takamura T. · 2026-09-14

   open access unreviewed
3. 3
   From molecules to medicine: the gut‒heart axis comes of age.

   Pretorius T, Marques FZ. · 2026-09-19

   open access unreviewed
4. 4
   Integrated transcriptomics and metabolomics reveal suppression of the PPAR α/γ pathway linking purine metabolism disorder to high-protein diet-induced hyperuricemia in goslings.

   Li X, Xie Y, Zhang M, Zou T, Zhong C, Rajput ZI, Bi S, Cao L. · 2026-08-04

   open access unreviewed
5. 5
   FHL2 production enabled new insight into its flexibility and unexpected binding stoichiometry with β-catenin.

   Logonder T, Prešern U, Gaber A. · 2026-08-20

   open access unreviewed
6. 6
   Microbial metabolite-driven mechanisms linking the gut microbiome to atherosclerosis: multi-omic and translational perspectives.

   Masiá M, Gutiérrez F. · 2026-08-19

   cited 1× open access unreviewed
7. 7
   Histidine-improved cancer immunosurveillance.

   Fidelle M, Reich E, Zitvogel L, Kroemer G. · 2026-08-13

   open access unreviewed
8. 8
   Biofilm forming capacity, sanitizer tolerance, and genetic characterization of persistent and non-persistent <i>Listeria monocytogenes</i> from artisan cheese processing environments.

   Aboagye EF, Forauer EC, Gilmour AJ, Blackwell HL, Cushman L, Herren CS, Farace PD, Denaro S, Felten L, Ballar… · 2026-07-15

   open access unreviewed
9. 9
   Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer.

   Doermann AS, Caspi A, Evans AE, Feci A, Entezari AA, Snook AE, Waldman SA. · 2026-07-26

   open access unreviewed
10. 10
    High resolution cryo-EM structure of the <i>Pseudomonas aeruginosa</i> OprM multidrug efflux pump provides target for rational inhibitor design.

    Ratliff AC, Botos I, Putti AM, Patil PP, Ramkumar A, Ghirlando R, Dekker JP, Buchanan SK. · 2026-06-27

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.